Leverage our omni-channel approach to grow your brand across Asia Pacific.
The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region.
As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.
A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD
30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787
Increased genetic knowledge has redefined precision medicine and therapeutic landscapes. Menarini Group is well positioned for a future of precision cancer care, where patients are given access to treatment options that are personalised to their individual needs. By creating and building innovative approaches, we seek to provide optimal care to patients with different cancers and make it accessible to everyone across the world.
At Menarini Asia-Pacific, our own oncology journey began with our in-licensing breakthrough cancer pain portfolio. Driven by our manifesto, “Committed to make a difference in Cancer Patients’ Lives”, we constantly invest in research development and work with valued stakeholders to deliver extraordinary service and cutting-edge resources to cancer patients and healthcare providers.